Drug
Who makes icatibant?
7 companies list icatibant as a human prescription drug, including under the names SAJAZIR. Forms: injection; injection, solution. Routes: subcutaneous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing icatibant
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Alembic Pharmaceuticals LimitedIndia | injection | ANDAANDA213773 | 2 | 7 |
| CIPLA PHARMACEUTICALS LIMITEDIndia | injection | ANDAANDA212446 | 1 | 7 |
| Fresenius Kabi USA, LLCUnited States | injection, solution | ANDAANDA208317 | 1 | 6 |
| Teva Pharmaceutical Industries Ltd.Canada | injection, solution | ANDAANDA210118 | 1 | 6 |
| Hikma Pharmaceuticals USA Inc.United States | injection, solution | ANDAANDA211021 | 1 | 4 |
| Cycle Pharmaceuticals Ltd-Uk | injection | ANDAANDA212446 | 1 | 0 |
| Eugia US LLC | injection, solution | ANDAANDA213521 | 1 | 0 |
Enquiry
Common questions
- Who makes icatibant?
- 7 companies list icatibant as a human prescription drug in the openFDA NDC Directory, led by Alembic Pharmaceuticals Limited, CIPLA PHARMACEUTICALS LIMITED, Fresenius Kabi USA, LLC, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals USA Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic icatibant?
- 7 companies list icatibant under an abbreviated new drug application (ANDA), the application type used for generics. Listing status is from the NDC Directory; it is not a statement of availability.